Abiopharma

🔍 Jacobson Matthew (Executive)

Company: Gitlab Inc. (GTLB)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Sold 495 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 325.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 529 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 347.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 499 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 328.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 827 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 543.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 49,349 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 9,079.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 66,183 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 66,797.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 235,382 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 193,722.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 346,845 shares of Class A Common Stock at $22.947 per share (Direct)
  Date: 2026-03-19 | Code: S | equity_swap_involved: false | shares_owned_after: 188,658.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 325 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 347 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 328 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 543 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 9,079 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 66,797 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 193,722 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Sold 188,658 shares of Class A Common Stock at $22.3684 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-19 | Code: H | shares_owned_after: 587,050.00 | Footnotes: F6

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.51 to $23.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
• F2: ICONIQ Strategic Partners III GP, L.P. ("ICONIQ III GP") is the sole general partner of each of ICONIQ Strategic Partners III, L.P. ("ICONIQ III") and ICONIQ Strategic Partners III-B, L.P. ("ICONIQ III-B"). ICONIQ Strategic Partners III TT GP, Ltd. ("ICONIQ III Parent GP") is the sole general partner of ICONIQ III GP. ICONIQ Strategic Partners IV GP, L.P. ("ICONIQ IV GP") is the sole general partner of each of ICONIQ Strategic Partners IV, L.P. ("ICONIQ IV") and ICONIQ Strategic Partners IV-B, L.P. ("ICONIQ IV-B"). ICONIQ Strategic Partners IV TT GP, Ltd. ("ICONIQ IV Parent GP") is the sole general partner of ICONIQ IV GP. ICONIQ Strategic Partners V GP, L.P. ("ICONIQ V GP") is the sole general partner of each of ICONIQ Strategic Partners V, L.P. ("ICONIQ V") and ICONIQ Strategic Partners V-B, L.P. ("ICONIQ V-B"). ICONIQ Strategic Partners V TT GP, Ltd. ("ICONIQ V Parent GP") is the sole general partner of ICONIQ V GP.
• F3: (continued) ICONIQ Strategic Partners VI GP, L.P. ("ICONIQ VI GP") is the sole general partner of each of ICONIQ Strategic Partners VI, L.P. ("ICONIQ VI") and ICONIQ Strategic Partners VI-B, L.P. ("ICONIQ VI-B"). ICONIQ Strategic Partners VI TT GP, Ltd. ("ICONIQ VI Parent GP") is the sole general partner of ICONIQ VI GP. ICONIQ Capital Group GP, LLC ("ICONIQ Investment GP") is the general partner of ICONIQ Investment Holdings, LP ("ICONIQ Investment"). Divesh Makan ("Makan") is the sole member of ICONIQ Investment GP. Makan and William J.G. Griffith ("Griffith") are the sole equity holders of ICONIQ III Parent GP. Makan, Griffith and the Reporting Person are the sole equity holders of each of ICONIQ IV Parent GP, ICONIQ V Parent GP and ICONIQ VI Parent GP.
• F4: The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
• F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.985 to $22.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
• F6: The shares are held by the Reporting Person through a trust of which he is a trustee. The Reporting Person disclaims beneficial ownership of the shares held by such trust for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.